Cpt1a plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis

HIGHLIGHTS

• who: Anne Sk and colleagues from the Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej, Aalborg, Denmark have published the research: CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis, in the Journal: Scientific Reports Scientific Reports of 10/05/2019
• what: This study focused on the unique concept of dysregulated lipid metabolism as the major contributor to disease since inhibition of lipid metabolism has been effective in animal models of MS and depression5 6. The aim of this study was to clarify the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.